Search

Purpose: The study aimed to develop a web-based education program among cancer patients undergoing treatment with systemic chemotherapy and to evaluate the efficacy of the program on symptom control, quality of life, self-efficacy, and depression., Methods: A web-based education program was prepared in line with patient needs, evidence-based guidelines, and expert opinions and tested with 10 cancer patients. The single-blind, randomized controlled study was conducted at a medical oncology unit of a university hospital. Pretests were applied to 60 cancer patients undergoing treatment with systemic chemotherapy, and the patients (intervention: 30, control: 30) were randomized. The intervention group used a web-based education program for 3 months, and they were allowed to communicate with researchers 24/7 via the website. The efficacy of a web-based education program at baseline and after 12 weeks was evaluated. The CONSORT 2010 guideline was performed., Results: In the first phase results of the study, it was found that most of the patients with cancer wanted to receive education about symptom management and the side effects of the treatment. Expert opinions on the developed website were found to be compatible with each other (Kendall's Wa = 0.233, p = 0.008). According to the randomized controlled study results, patients who received web-based education reported significantly fewer symptoms (p = 0.026) and better quality of life (p = 0.001), but there was no statistically significant difference in the self-efficacy and depression levels during the 3-month follow-up period (p˃0.05). The most frequently visited links in the web-based education program by the patients with cancer were the management of chemotherapy-related symptoms (62.6%)., Conclusion: A web-based education program was found to be efficacy in remote symptom management and improving the quality of life of cancer patients., Trial Registration: www., Clinicaltrials: gov , NCT05076916 (October 12, 2021, retrospectively registered)., (© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)

Background: Testicular cancer is a rare type of cancer in males. Since the disease is seen in young men and long-term survival is ensured following a high treatment success rate, fertility in testicular cancer patients is much more important. Prior to commencement of cancer treatment, patients are given counselling with regard to infertility and sexual function, and sperm banking is commonly carried out. The aim of this study was to assess the fertility status prior to and following treatment of monitored testicular cancer patients whose treatment had been completed., Methods: 110 patients diagnosed with and treated for testicular cancer at the Medical Oncology Clinic at Akdeniz University during the years 2000-2016 were evaluated for the study. The patients' disease and treatment information was obtained from their records. The patients' characteristics and fertility statuses were determined by means of interviews with the patients., Results: The median age of the patients was 36 (20-73) and 39.1% of them (n = 43) were aged between 30 and 39. The average length of follow-up was 6.20 ± 3.36 (2-17) years. It was determined that 42.7% of the patients had banked sperm following diagnosis and that 74.5% of them had received counselling. Following treatment, 33 patients (30%) fathered children. The average time taken to father children after treatment was 3 years., Conclusion: In testicular cancer patients, fatherhood is achieved spontaneously or with the cryopreservation process. Counselling plays an important role at the time of diagnosis. It is essential that health professionals in oncology clinics give counselling about fertility in testicular cancer.

The updated version of Table 4 of original publication and the Compliance with ethical standards are given in this correction.

Background: Cancer patients are known to commonly use complementary therapies (CT). However, it is emphasized that patients do not share sufficient information with health professionals about this subject and that the subject is ignored in oncology practice. The aim of the study is to assess cancer patients' reasons for using complementary therapy, information resources and communication with health professionals., Methods: The study is a descriptive, cross-sectional study. In this study, a questionnaire was used by the researchers. A questionnaire form consisting of 3 parts was used. In the first part of this form, there were questions about the gender, age and educational status of the patients (8 questions). In the second part, there were questions about disease and treatment information (3 questions), and the third part had questions about the use of complementary therapies (9 questions). To determine the use of complementary therapy, patients were asked 'Do you currently use complementary treatment?' (Yes or No). 183 patients included in the study completed the questionnaire about complementary therapies., Results: In this study, it was determined that 37.7% of the patients were using complementary therapies. The most commonly used complementary therapy was natural products (46.4%). The most common reason for using complementary therapy was to provide support for treatment. Almost half of the cancer patients (48.5%) did not talk about this issue with their physicians, and 41.1% of them did not talk about CT with their nurses. The study found that the most important reason why the patients did not talk about CT was that they were not asked about it by health professionals., Conclusion: This study determined that almost half of patients could not receive information about CT from health professionals. Patients expect physicians and nurses to initiate communication on this subject. Providing healthcare professionals with evidence-based counseling about CT is essential for improving patient safety and patient outcomes., (Copyright © 2019 Elsevier Ltd. All rights reserved.)